Tag: eli lilly

eli lilly

Latest News

Obesity drugs including Wegovy are displayed at a pharmacy in Jongno District, central Seoul, on Dec. 2, 2024. [YONHAP]

Wegovy maker Novo Nordisk to slash 9,000 jobs as competition heats up

Novo Nordisk will cut 9,000 jobs and restructure to save $1.3 billion annually amid increased competition for Wegovy and Ozempic, expecting slower growth.

2025.9.10

A pharmacist displays a box of Mounjaro, a tirzepatide injection drug used for treating type 2 diabetes made by Eli Lilly at Rock Canyon Pharmacy in Provo, Utah, on March 29, 2023. [REUTERS/YONHAP]

Eli Lilly's Mounjaro to land in Korea, setting off price war with Wegovy

Eli Lilly’s cut-price Mounjaro lands in Korea next week, ending Novo Nordisk’s domestic monopoly and igniting a price war in the weight loss drug market, while Wegovy will switch to tiered pricing in a global first.

2025.8.13

Most popular

Olix, Eli Lilly to develop liver disease drug under $630 million deal

Olix Pharmaceuticals signed a $630 million licensing deal with Eli Lilly to develop treatments for cardiovascular and metabolic diseases.

2025.2.10

Hanmi Pharmaceutical Senior Vice President Choi In-young, head of the R&D center, speaks to Korean media outlets at a press conference held in San Francisco, California, on Jan. 15. [LEE JAE-LIM]

Hanmi seeks to gain on Wegovy with its own weight-loss drug

Hanmi Pharmaceutical is working on its own range of weight-loss treatments tailored to the Korean market.

2025.1.16

Novo Nordisk's weight-loss drug Wegovy [JOONGANG PHOTO]

Korean pharmas jump on weight loss drug boom

The popularity of Novo Nordisk's weight-loss drug Wegovy has made the Danish company the most valuable in Europe; Korean pharmas are now seeking a share of the lifestyle drugs market.

2023.9.20